“Since its introduction five years ago, the BD FACSAria system has made cell sorting accessible to a broad audience of researchers, making it the workhorse of the global research community,” said William Rhodes, President, Cell Analysis, BD Biosciences. “Working closely with our customers, we designed improvements across the system to make BD FACSAria II even easier to use and more productive.”
Some key improvements include: New fluidics design to support aseptic setup and cleaning • New nozzle sizes to allow sorting of a range of particles • New 375-nm Near UV laser option to expand the range of application choices • New BD FACSDiva™ software that includes a Cytometer Setup and Tracking feature to enhance workflow and productivity by automating quality control and experiment setup
The BD FACSAria design is based on a true fixed alignment flow cell that is gel-coupled to the collection optics. This unique and revolutionary design minimizes startup time, improves experiment-to-experiment reproducibility, and increases the sensitivity and resolution needed for multicolor applications. BD Biosciences offers comprehensive solutions for life science researchers. These include consulting and support services for technical and application needs and compatible, state-of-the-art instruments as well as a full line of assays and reagents.
The current BD FACSAria cell sorter will be field upgradeable to the BD FACSAria II cell sorter. For more information about the BD FACSAria II system, please visit: http://www.bdbiosciences.com/facsaria2.
About BD BD, a leading global medical technology company that manufactures and sells medical devices, instruments and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit www.bd.com.
